Skip to content
FDA.report
Public FDA data
NDC
RxNorm
DailyMed
Applications
GUDID
GMDN
PMA
PMN
MAUDE
Recalls
Search FDA.report
Search
Home
DailyMed
product-concept
4ea6ac43-4fcd-46cf-8d11-c79e5b99f91c
TAFENOQUINE SUCCINATE - Food and Drug Administration
Set ID
4ea6ac43-4fcd-46cf-8d11-c79e5b99f91c
Type
Indexing - product concept
Effective date
2018-10-02
Version
1
Source
DailyMed source
Mapped DailyMed Labels
#
Label, Relation, Manufacturer table
Label
Relation
Manufacturer
Effective
60 Degrees Pharmaceuticals, INC | Piramal Pharma Limited human prescription drug label
Product name
60 Degrees Pharmaceuticals, INC | Piramal Pharma Limited
2025-02-10
These highlights do not include all the information needed to use ARAKODA™ safely and effectively. See full prescribing information for ARAKODA™. ARAKODA™ (tafenoquine) tablets, for oral use Initial U.S. Approval: 2018
Product name
60 Degrees Pharmaceuticals, INC. | TENTAMUS INDIA PRIVATE LIMITED
2025-01-10
These highlights do not include all the information needed to use KRINTAFEL safely and effectively. See full prescribing information for KRINTAFEL. KRINTAFEL (tafenoquine) tablets, for oral use Initial U.S. Approval: 2018
Product name
GlaxoSmithKline LLC
2023-08-02
These highlights do not include all the information needed to use KRINTAFEL safely and effectively. See full prescribing information for KRINTAFEL. KRINTAFEL (tafenoquine) tablets, for oral use Initial U.S. Approval: 2018
Product name
GlaxoSmithKline LLC
2023-08-02
Related NDC Packages
#
NDC, DailyMed label, Manufacturer table
NDC
DailyMed label
Manufacturer
0173-0889
These highlights do not include all the information needed to use KRINTAFEL safely and effectively. See full prescribing information for KRINTAFEL. KRINTAFEL (tafenoquine) tablets, for oral use Initial U.S. Approval: 2018
GlaxoSmithKline LLC
0173-0889-39
These highlights do not include all the information needed to use KRINTAFEL safely and effectively. See full prescribing information for KRINTAFEL. KRINTAFEL (tafenoquine) tablets, for oral use Initial U.S. Approval: 2018
GlaxoSmithKline LLC
71475-257
These highlights do not include all the information needed to use ARAKODA™ safely and effectively. See full prescribing information for ARAKODA™. ARAKODA™ (tafenoquine) tablets, for oral use Initial U.S. Approval: 2018
60 Degrees Pharmaceuticals, INC. | TENTAMUS INDIA PRIVATE LIMITED
71475-257-01
These highlights do not include all the information needed to use ARAKODA™ safely and effectively. See full prescribing information for ARAKODA™. ARAKODA™ (tafenoquine) tablets, for oral use Initial U.S. Approval: 2018
60 Degrees Pharmaceuticals, INC. | TENTAMUS INDIA PRIVATE LIMITED
71475-257-02
These highlights do not include all the information needed to use ARAKODA™ safely and effectively. See full prescribing information for ARAKODA™. ARAKODA™ (tafenoquine) tablets, for oral use Initial U.S. Approval: 2018
60 Degrees Pharmaceuticals, INC. | TENTAMUS INDIA PRIVATE LIMITED
71475-258
60 Degrees Pharmaceuticals, INC | Piramal Pharma Limited DailyMed label
60 Degrees Pharmaceuticals, INC | Piramal Pharma Limited
71475-258-03
60 Degrees Pharmaceuticals, INC | Piramal Pharma Limited DailyMed label
60 Degrees Pharmaceuticals, INC | Piramal Pharma Limited